sodium (E)-7-[4'-fluoro-5,6-dimethoxy-3-(propan-2-yl)biphenyl-2-yl]-3,5-dihydroxy-6-heptenoate

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: sodium (E)-7-[4'-fluoro-5,6-dimethoxy-3-(propan-2-yl)biphenyl-2-yl]-3,5-dihydroxy-6-heptenoate
• 英文别名: sodium;(E)-7-[2-(4-fluorophenyl)-3,4-dimethoxy-6-propan-2-ylphenyl]-3,5-dihydroxyhept-6-enoate
• 化学式: C₂₄H₂₈FO₆*Na
• 分子量: 454.471
• InChiKey: JDJSQEXHHJAUME-RRABGKBLSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  32
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  99
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  Ethyl (E)-7-[4'-fluoro-5,6-dimethoxy-3-(propan-2-yl)biphenyl-2-yl]-3,5-dihydroxy-6-heptenoate 在 sodium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 以117 mg (97.2%)的产率得到sodium (E)-7-[4'-fluoro-5,6-dimethoxy-3-(propan-2-yl)biphenyl-2-yl]-3,5-dihydroxy-6-heptenoate
  参考文献：
  名称：

  Heptanoate derivatives

  摘要：

  公式（I）的庚酸酯衍生物：其中R¹和R²分别是氢原子或羟基的保护基，或R¹和R²整体构成羟基的保护基；而R³是氢原子，烷基或芳香族碳氢基团。

  公开号：

  EP0633242A1

文献信息

• 4-fluorobiphenyl derivatives
  申请人：Fujirebio Inc.

  公开号：US05523460A1

  公开（公告）日：1996-06-04

  A 4-fluorobiphenyl derivative of formula (I), which is useful as a cholesterol lowering agent or a lipid lowering agent because of its strong inhibitory effect on HMG-CoA reductase), and which is also useful as an intermediate for producing the above-mentioned cholesterol lowering agent or lipid lowering agent: ##STR1## wherein A is a .omega.-oxycarbonyldihydroxybutyl group, a tetrahydropyranyl group, a .omega.-oxycarbonyl-3-oxobutyl group, a formyl group, or a cyano group; R.sup.1 is a halogen atom, an alkyl group, or a group represented by R.sup.5 O--, wherein R.sup.5 is a hydrogen atom, or an alkyl group; R.sup.2 is a hydrogen atom, an alkyl group; R.sup.3 is a hydrogen atom, or an alkyl group; R.sup.5 and R.sup.2 may form a five-membered ring or a six-membered ring in combination with the oxygen atoms to which R.sup.5 and R.sup.2 are respectively bonded, and R.sup.5 and R.sup.3 may form a five-membered ring or a six-membered ring in combination with the oxygen atom to which R.sup.5 is bonded.

  一种具有化学式（I）的4-氟联苯衍生物，由于其对HMG-CoA还原酶具有强烈的抑制作用，可用作降胆固醇剂或降脂剂，并且还可用作生产上述降胆固醇剂或降脂剂的中间体：##STR1## 其中A是ω-氧羰基二羟基丁基基团、四氢吡喃基团、ω-氧羰基-3-氧代丁基基团、甲酰基团或氰基；R1是卤素原子、烷基基团或由R5 O--表示的基团，其中R5是氢原子或烷基基团；R2是氢原子或烷基基团；R3是氢原子或烷基基团；R5和R2可以分别与它们相结合的氧原子形成五元环或六元环，R5和R3可以与R5结合的氧原子形成五元环或六元环。
• Heptanoate derivatives
  申请人：FUJIREBIO Inc.

  公开号：EP0633242A1

  公开（公告）日：1995-01-11

  A heptanoate derivative of formula (I): wherein R¹ and R² are independently a hydrogen atom or a protective group for hydroxyl group, or R¹ and R² integrally constitute a protective group for hydroxyl groups; and R³ is a hydrogen atom, an alkyl group, or an aromatic hydrocarbon group.

  公式（I）的庚酸酯衍生物：其中R¹和R²分别是氢原子或羟基的保护基，或R¹和R²整体构成羟基的保护基；而R³是氢原子，烷基或芳香族碳氢基团。
• Methods of producing carboxylic acid ester derivatives and intermediates
  申请人：Fujirebio Inc.

  公开号：US05481009A1

  公开（公告）日：1996-01-02

  Methods of producing carboxylic acid ester derivatives of formulae (I) and (II), which are useful, for instance, as intermediates for producing an anti-hypercholesterolemic agent having an inhibitory effect on HMG-CoA Reductase: ##STR1## wherein R.sup.1 and R.sup.2 are independently a protective group for hydroxyl group, or R.sup.1 and R.sup.2 integrally constitute a protective group for hydroxyl groups; R.sup.3 is an alkyl group, or an aryl group; and R.sup.4 is a substituted aryl group, a substituted heterocyclic group, a substituted vinyl group, or a substituted cycloalkenyl group; and ##STR2## wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are respectively the same as defined in the above formula (I), are disclosed. In addition, intermediates for use in these methods of producing the carboxylic acid ester derivatives are disclosed.

  生产具有以下式(I)和(II)的羧酸酯衍生物的方法，例如，作为生产对HMG-CoA还原酶具有抑制作用的抗高胆固醇药物的中间体：##STR1## 其中R.sup.1和R.sup.2分别是羟基的保护基，或者R.sup.1和R.sup.2整体构成羟基的保护基；R.sup.3是烷基，或芳基；R.sup.4是取代芳基，取代杂环基，取代乙烯基，或取代环烯基；和##STR2## 其中R.sup.1，R.sup.2，R.sup.3和R.sup.4分别与上述式(I)中定义的相同，被揭示。此外，还揭示了用于这些生产羧酸酯衍生物的方法的中间体。